PGM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.922400E-01
Normal-vs-Stage2
8.628600E-01
Normal-vs-Stage3
4.082400E-01
Normal-vs-Stage4
7.509000E-01
Stage1-vs-Stage2
3.748100E-02
Stage1-vs-Stage3
9.242000E-01
Stage1-vs-Stage4
1.903360E-01
Stage2-vs-Stage3
1.083390E-01
Stage2-vs-Stage4
6.649800E-01
Stage3-vs-Stage4
2.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.942000E-01
Normal-vs-AfricanAmerican
8.552600E-01
Normal-vs-Asian
6.574400E-01
Caucasian-vs-AfricanAmerican
1.300550E-01
Caucasian-vs-Asian
3.656600E-01
AfricanAmerican-vs-Asian
3.426000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.640400E-01
Normal-vs-Female
8.394000E-01
Male-vs-Female
3.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.673000E-01
Normal-vs-Age(41-60Yrs)
9.689400E-01
Normal-vs-Age(61-80Yrs)
7.265000E-01
Normal-vs-Age(81-100Yrs)
5.862200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.973640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.230000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.133400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.540300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.046800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.427800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.395800E-01
Normal-vs-Daily Drinker
6.387800E-01
Normal-vs-Weekly Drinker
6.898600E-01
Normal-vs-Occasional Drinker
8.818000E-01
Normal-vs-Social Drinker
8.545400E-01
Non Drinker-vs-Daily Drinker
3.217200E-01
Non Drinker-vs-Weekly Drinker
5.848000E-01
Non Drinker-vs-Occasional Drinker
6.230800E-01
Non Drinker-vs-Social Drinker
7.489800E-01
Daily Drinker-vs-Weekly Drinker
7.381200E-01
Daily Drinker-vs-Occasional Drinker
9.618100E-02
Daily Drinker-vs-Social Drinker
1.534640E-01
Weekly Drinker-vs-Occasional Drinker
2.608800E-01
Weekly Drinker-vs-Social Drinker
3.479800E-01
Occasional Drinker-vs-Social Drinker
8.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.715200E-01
Normal-vs-Grade 2
9.914200E-01
Normal-vs-Grade 3
8.174000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.306400E-02
Grade 1-vs-Grade 3
1.288270E-02
Grade 1-vs-Grade 4
5.715200E-01
Grade 2-vs-Grade 3
3.144400E-01
Grade 2-vs-Grade 4
9.914200E-01
Grade 3-vs-Grade 4
8.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.678000E-01
Normal-vs-NonDiabetic
8.036200E-01
Diabetic-vs-NonDiabetic
7.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.141600E-01
Normal-vs-NoPancreatitis
7.812200E-01
Pancreatitis-vs-NoPancreatitis
4.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.937600E-01
Normal-vs-N1
8.591600E-01
N0-vs-N1
5.356100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.668800E-01
Normal-vs-TP53-NonMutant
6.335000E-01
TP53-Mutant-vs-TP53-NonMutant
2.540200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
